-+ 0.00%
-+ 0.00%
-+ 0.00%

FDA APPROVES FIRST IN CLASS TARGETED THERAPY FOR METASTATIC PANCREATIC CANCER

Reuters·08/26/2026 14:38:27

Please log in to view news